Advanced search    

Search: authors:"David M. Kern"

4 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Treatment Patterns of Newly Diagnosed Rheumatoid Arthritis Patients from a Commercially Insured Population

this version to be published. Disclosures. David M Kern is a former employee of HealthCore, Inc. Kalyani Sonawane is a former employee of HealthCore, Inc. Lawrence Chang is a former employee of Eli

Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study

Background Inhaled corticosteroid/long-acting β2-agonist combinations (ICS/LABA) have emerged as first line therapies for chronic obstructive pulmonary disease (COPD) patients with exacerbation history. No randomized clinical trial has compared exacerbation rates among COPD patients receiving budesonide/formoterol combination (BFC) and fluticasone/salmeterol combination (FSC) to...

Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study

as a result of grants or contracts, other than her salary from HealthCore. David M. Kern receives no direct compensation as a result of grants or contracts other than his salary from HealthCore

T Cell Activation and Senescence Predict Subclinical Carotid Artery Disease in HIV-Infected Women

ARTICLEBackground. Individuals infected with human immunodeficiency virus (HIV) have increased risk of cardiovascular events. It is unknown whether T cell activation and senescence, 2 immunologic sequelae of HIV infection, are associated with vascular disease among HIV-infected adults. Methods. T cell phenotyping and carotid ultrasound were assessed among 115 HIV-infected women...